CLINICAL_TRIALS
research
· 2026-02-24
Clinical Trial Update: A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
Summary
A Phase 2 clinical trial update evaluating INCB099280 in participants with advanced cutaneous squamous cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING